LOTRIMIN AF Powder Spray Recalled for Benzene Contamination Risk
Bayer Healthcare is recalling LOTRIMIN AF (Miconazole nitrate 2%) Powder Spray because it was manufactured at a facility where other lots were found contaminated with benzene. The recall affects multiple lot numbers distributed nationwide in the US, Puerto Rico, Canada, and Mexico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall involving a known contamination hazard (benzene) at a manufacturing facility. Benzene is a known carcinogen and reproductive/developmental toxicant, making this a serious manufacturing defect that warrants a Severe classification even though no reported illnesses are stated in the source text.
Plain-English summary
Bayer Healthcare Pharmaceuticals Inc. is recalling LOTRIMIN AF (Miconazole nitrate 2%) Powder Spray in 133g (4.6 oz) cans due to cGMP (current Good Manufacturing Practice) deviations. The affected product was manufactured at the same facility where other lots were found to be contaminated with benzene.
The recall involves specific lot numbers with expiration dates ranging from October 2021 through June 2023. The product was distributed nationwide in the United States, Puerto Rico, Canada, and Mexico through various retail channels.
Consumers who have purchased this product should stop using it immediately. Consumers with questions or concerns should contact Bayer Healthcare or consult their healthcare provider.
The recalled product
- Product
- LOTRIMIN AF (Miconazole nitrate 2%) Powder Spray NET WT 133g (4.6 OZ) can, packaged as (a) a single pack NDC 11523-0544-2 UPC 3 11017 41025 7; (b) 3 pack, NDC 11523-0544-2, UPC 0 41100 58594 3; Dist by: Bayer Healthcare LLC, Whippany, NJ 07981, Product of Spain, ,
- Manufacturer
- Bayer Healthcare Pharmaceuticals Inc.
- Category
- Drug — Topical Antifungal
- Hazard
- benzene-contamination
- cGMP-deviations
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot # (a) CV017D9
- EXP 10/31/2021
- CV01940
- EXP 11/30/2021
- CV01CD9
- EXP 4/30/2022
- CV01D9T
- CV01DZ3
- EXP 6/30/2022
- CV01EPP
- EXP 7/31/2022
- TN000TT
- EXP 10/31/2022
- TN003CG
- EXP 1/31/2023
- TN003CH
- TN00407
- EXP 3/31/2023
- TN0041V
- EXP 6/30/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27